back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-11 14:53 Tx date 2022-05-11 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$466.00
+100 vol $4.66 each |
2,506 | |
| Filed 2022-05-11 14:53 Tx date 2022-05-11 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$453.00
+100 vol $4.53 each |
2,406 | |
| Filed 2022-05-11 14:52 Tx date 2022-05-11 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+200 vol $4.50 each |
2,306 | |
| Filed 2022-05-11 14:52 Tx date 2022-05-11 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$440.00
+100 vol $4.40 each |
2,106 | |
| Filed 2021-07-06 19:44 Tx date 2021-06-29 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,963
+3,151,639 vol $0.0479 each |
9,628,533 | |
| Filed 2020-11-30 10:41 Tx date 2020-11-26 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,435
+137,431 vol $0.025 each |
401,278 | |
| Filed 2020-04-02 17:16 Tx date 2020-03-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$244,173
+5,402,068 vol $0.0452 each |
6,476,894 | |
| Filed 2019-08-09 15:56 Tx date 2019-08-08 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+324,826 vol |
1,074,826 | |
| Filed 2019-03-29 Tx date 2019-03-29 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+153,847 vol $0.195 each |
263,847 | |
| Filed 2018-11-30 Tx date 2018-11-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$77.50
+500 vol $0.155 each |
110,000 | |
| Filed 2018-11-30 Tx date 2018-11-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,320
+14,500 vol $0.16 each |
109,500 | |
| Filed 2018-11-21 Tx date 2018-11-21 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+10,000 vol $0.18 each |
95,000 | |
| Filed 2018-11-20 Tx date 2018-11-20 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
85,000 | |
| Filed 2018-11-19 Tx date 2018-10-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-19 Tx date 2018-11-19 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2018-11-19 Tx date 2018-10-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-19 Tx date 2018-11-19 |
$ASP
Acerus Pharmaceuticals Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,750
+75,000 vol $0.17 each |
75,000 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$HYG
Hydrogenics Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,691.76
-452 vol $10.38 each |
1,115 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$HYG
Hydrogenics Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-829 vol |
0 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$HYG
Hydrogenics Corporation |
Motz, Robert Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+829 vol |
1,567 |